Belgian mathematician hopes to use the science of chaos, the butterfly effect and strange attractors to help build a complete model of climate and resources that will lead to a new approach to sustainable development. Jacques Nihoul of the department of Model Environment at the University of Liège, in Belgium, writing in the inaugural issue of the International Journal of Computing Science and Mathematics published by Inderscience, explains how a new approach to sustainable development and climate change could emerge from his research.

Particles of light serving as “quantum keys”—the latest in encryption technology—have been sent over a record-setting 200-kilometer fiber-optic link by researchers from the National Institute of Standards and Technology (NIST), NTT Corp. in Japan, and Stanford University.

The experiment, using mostly standard components and transmitting at telecommunications frequencies, offers an approach for making practical inter-city terrestrial quantum communications networks as well as long-range wireless systems using communication satellites.

A new test for diagnosing Tuberculosis offers a quick and simple alternative to existing three-day methods, according to research published today in the journal Clinical Infectious Diseases.

The study shows that the test, which involves taking three sputum samples from a patient over the course of one day, is just as effective as other more invasive and complicated testing methods, which take three days.

Aspirin didn’t pan out. Neither did two other potential anti-aging agents. But a synthetic derivative of a pungent desert shrub is now a front- runner in ongoing animal experiments to find out if certain chemicals, known to inhibit inflammation, cancer and other destructive processes, can boost the odds of living longer.

University of Michigan scientist Richard A. Miller reports early results from a mouse study his lab and two others are conducting for the National Institute on Aging. The study, now in its fourth year, will test as many as two dozen possible anti-aging agents in animals in the next five years.

Based on clues provided by a study with transgenic mice, a research group at the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH), has developed a strategy that will be tested as the first treatment for people with hereditary inclusion body myopathy (HIBM), a rare, degenerative muscle disease. In an unexpected finding, the research indicates that the approach also might benefit patients with certain kidney disorders.

The wild tiger now occupies a mere 7 percent of its historic range, and the area known to be inhabited by tigers has declined by 41 percent over the past decade, according to an article published in the June 2007 issue of BioScience.

Growing trade in folk medicines made from tiger parts and tiger skins, along with habitat loss and fragmentation, is believed to be the chief reason for the losses. The assessment, by Eric Dinerstein of the World Wildlife Fund and 15 coauthors, describes the wild tiger's population trajectory as "catastrophic" and urges international cooperation to ensure the animal's continued existence in the wild.

The science has long been clear that smoking causes cancer, but new research shows that children could inherit genetic damage from a father who smokes.

Canadian researchers have demonstrated in mice that smoking can cause changes in the DNA sequence of sperm cells, alterations that could potentially be inherited by offspring.

“When we began the Human Genome Project, we anticipated it would take 15 years to sequence the 3 billion base pairs and identify all the genes,” said Dr. Richard Gibbs, director of the Human Genome Sequencing Center. “We completed it in 13 years in 2003 – coinciding with the 50th anniversary of the publication of the work of Watson and Dr. Francis Crick that described the double helix.

"Today, we give James Watson a DVD containing his personal genome – a project completed in only two months. It demonstrates how far the sequencing technology has come in a short time.”

A new vaccine aimed at preventing cervical cancer is nearly 100 percent effective against the two types of the human papillomavirus (HPV) responsible for most cases of cervical cancerÑstrains 16 and 18.

In the current and largest study to date, researchers combined and analyzed the data from four randomized trials that involved 20,583 women ages 15 to 26 from more than two dozen countries across Europe, North America, Latin America and Asia. Participants were randomly assigned to receive the HPV vaccine or placebo and followed for an average of three years.